CyberKnife SBRT plus lenvatinib and tislelizumab versus doublet systemic therapy for hepatocellular carcinoma with macrovascular invasion: A real-world IPTW-adjusted study

Clinical and Translational Radiation Oncology · Elsevier

Аннотация

Publication date: January 2027 Source: Clinical and Translational Radiation Oncology, Volume 62 Author(s): Sujing Zhang, Xiaoqian Shen, Wei Wang, Miaomiao Zhang, Suming Wang, Hui Hao, Yingchun Zhao

Читать у издателя →

Похожие статьи